Saltar al contenido
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Lenguaje
Todos los Campos
Título
Autor
Materia
Número de Clasificación
ISBN/ISSN
Etiqueta
Buscar
Avanzado
Do Diuretics, Beta-Blockers, a...
Citar
Describir
Enviar este por Correo electrónico
Imprimir
Exportar Registro
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enlace Permanente
Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
Detalles Bibliográficos
Autores principales:
Shen, L
,
Shah, B
,
Reyes, E
,
Thomas, L
,
Diem, P
,
Leiter, L
,
Charbonnel, B
,
Mareev, V
,
Horton, E
,
Haffner, S
,
Soska, V
,
Holman, R
,
Bethel, M
,
Schaper, F
,
Sun, J
,
McMurray, J
,
Califf, R
,
Krum, H
Formato:
Journal article
Publicado:
2012
Existencias
Descripción
Ejemplares similares
Vista Equipo
Ejemplares similares
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
por: Shen, L, et al.
Publicado: (2013)
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
por: McMurray, J, et al.
Publicado: (2012)
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
por: Mcmurray, J, et al.
Publicado: (2012)
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
por: Krum, H, et al.
Publicado: (2010)
Association of non-alcoholic steatothepatitis with components of the metabolic syndrome in 43,509 patients screened for NAVIGATOR
por: Bethel, A, et al.
Publicado: (2005)